Roselie M H Diederen
Overview
Explore the profile of Roselie M H Diederen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pauleikhoff L, Chang-Wolf J, Diederen R, Moll A, Schlingemann R, van Dijk E, et al.
Retina
. 2025 Feb;
PMID: 39913786
Purpose: Venous overload choroidopathy (VOC), showing pachyvessels, choroidal intervortex venous anastomoses (CVA), asymmetric venous drainage (AVD), choroidal vascular hyperpermeability (CVH) and increased choroidal thickness (CT), is observed in the vast...
2.
Balfoort B, Van den Broeck F, Boon C, Brouwers M, Diederen R, Dhillon P, et al.
J Inherit Metab Dis
. 2025 Jan;
48(1):e12842.
PMID: 39761806
Gyrate atrophy of the choroid and retina (GACR, OMIM #258870) is a rare inherited metabolic disorder characterized by progressive chorioretinal degeneration and hyperornithinemia. Current therapeutic modalities potentially slow disease progression...
3.
Brandsen R, Biemond B, Nur E, Chang-Wolf J, Schlingemann R, Diederen R
Retina
. 2025 Jan;
PMID: 39761517
Purpose: To evaluate the presence and progression of maculopathy in patients with sickle cell disease (SCD) using Optical Coherence Tomography (OCT) and OCT-Angiography (OCTA), and to identify clinical/laboratory risk factors...
4.
Brandsen R, Diederen R, Kocabas G, Nur E, Malekzadeh A, Schlingemann R, et al.
Haematologica
. 2024 Dec;
PMID: 39704162
Sickle cell retinopathy (SCR) is a complication of sickle cell disease (SCD) and can drastically impair visual acuity. Screening for SCR is therefore recommended, but evidence for optimal screening frequency...
5.
Brandsen R, Biemond B, Nasim G, Nur E, Schlingemann R, Diederen R
Retina
. 2024 Aug;
44(12):2185-2195.
PMID: 39163633
Purpose: To evaluate macular abnormalities in sickle cell disease with optical coherence tomographic angiography and to determine associations with sickle cell retinopathy (SCR) and clinical and laboratory characteristics. Methods: Complete...
6.
Balfoort B, Van den Broeck F, Brands M, van Karnebeek C, Bergen A, van den Born L, et al.
Graefes Arch Clin Exp Ophthalmol
. 2024 Jun;
262(11):3589-3596.
PMID: 38847892
Purpose: Gyrate atrophy of the choroid and retina (GACR) is an autosomal recessive inherited metabolic disorder (IMD) characterised by progressive retinal degeneration, leading to severe visual impairment. The rapid developments...
7.
Sirks M, Subhi Y, Rosenberg N, Hollak C, Boon C, Diederen R, et al.
Ophthalmol Ther
. 2024 May;
13(7):1821-1831.
PMID: 38753294
An ongoing global shortage of verteporfin (Visudyne) limits the treatment possibilities for several chorioretinal diseases, including central serous chorioretinopathy, choroidal hemangioma, and polypoidal choroidal vasculopathy. Verteporfin is required to perform...
8.
Pauleikhoff L, Diederen R, Chang-Wolf J, Moll A, Schlingemann R, van Dijk E, et al.
Acta Ophthalmol
. 2024 Apr;
102(6):e946-e955.
PMID: 38561630
Purpose: Choroidal vascular hyperpermeability (CVH) on indocyanine green angiography (ICGA) is a hallmark feature of central serous chorioretinopathy (CSC). We identified three distinct CVH phenotypes in CSC: uni-focal indistinct signs...
9.
Feenstra H, van Dijk E, Cheung C, Ohno-Matsui K, Lai T, Koizumi H, et al.
Prog Retin Eye Res
. 2024 Feb;
101:101236.
PMID: 38301969
Central serous chorioretinopathy (CSC) is a relatively common disease that causes vision loss due to macular subretinal fluid leakage and it is often associated with reduced vision-related quality of life....
10.
Hensman J, Hahn L, van Schooneveld M, Diederen R, Ten Brink J, Florijn R, et al.
Ophthalmol Retina
. 2023 Dec;
8(6):600-606.
PMID: 38104928
Purpose: To date, there is no standard treatment regimen for carbonic anhydrase inhibitors (CAIs) in X-linked retinoschisis (XLRS) patients. This retrospective study aims to evaluate the efficacy of CAIs on...